Drug reaction eosinophilia with systemic symptoms (DRESS) syndrome is a potentially life threatening condition secondary to the usage of a wide type of drugs. A 38-year-old woman under allopurinol therapy for hyperuricemia was admitted in our department with fever and a diffuse cutaneous erythematous eruption. A few days after admission she developed rapidly progressive signs of acute liver and kidney failure. Subsequently, her clinical conditions shortly improved. The histologic findings obtained from skin and liver biopsies were consistent with a toxic drug reaction. The patient completely recovered and has been healthy for five years. 
A 38-year-old woman was admitted to our department due to intermittent daily fever with peaks up to 38 that begun 20 days prior. Thirty days before, the patient was admitted to the Emergency Department due to severe hypertension and dyspnea: in this occasion, chest radiography showed mild signs of heart failure and an echocardiogram documented mild left ventricular hypertrophy with preserved ejection fraction. The blood tests (including complete blood cell count), and the hepatic and renal function indices were all within the normal limits. At discharge, the patient was treated with losartan, low-dose hydrochlorothiazide and allopurinol due to the occurrence of hyperuricemia (9 mg/100 mL) and a complete ambulatory evaluation for newly diagnosed hypertension was also scheduled two months later.
On admission, the patient was febrile (37.8 ) without any others symptoms. No abnormalities were found on the clinical examination. Two days later, the patient developed a diffuse cutaneous erythematous eruption, mostly located in the light exposed regions (e.g., the face, hands, arms and legs). Moreover, mild arthralgia located to both the shoulders and hips was present. A blood examination showed normal PCR and ESR, mild eosinophilia (12%) and testing for autoimmune disorders, such as antinuclear antibodies, the Waaler Rose test, anti citrullinated proteins, antineutrophil, anti-GLP 1 and anti-phospholipid antibodies were all negative.
All drugs treatments were withdrawn. A complete diagnostic work up for fever of unknown origin (FUO), which included an abdominopelvic ultrasound examination, a total body computer tomography scan, transthoracic and transesophageal echocardiography, was negative. The patient refused to undergo a bone marrow biopsy.
A medium dose steroid treatment was initiated (1 mg/kg of prednisone) and an almost complete remission of the symptoms was obtained. The patient was discharged on steroid therapy and a follow-up visit seven days later was scheduled. Four days later, the patient was readmitted with fever, profuse diarrhea, acute renal failure and erythematous diffuse cutaneous reaction: furthermore, antinuclear antibodies were positive and rapidly progressive signs of acute liver failure occurred over the next three days despite high dose steroid therapy (i.e., very high AST and ALT blood levels, a decline in the serum proteins and albumin, severe impair- ment of blood coagulation parameters). All the viral hepatitis markers (HCV; HBsAg, IgM anti C, HSV) were negative. No storage liver disorders (e.g., hemochromatosis and Wilson's disease) were identified. The patient was transferred to the Intensive Care Unit of a tertiary hospital for liver transplantation. Over the next fifteen days, the patient's clinical conditions gradually improved and both liver and skin biopsies were performed ( Figure) . The skin histology ( Figure A, B) showed eosinophilic leucocyte perivascular infiltration and edema that were regarded to be consistent with a toxic drug reaction. The liver histology (Figure C, D) showed acute cellular damage and a lobular inflammatory pattern consistent with drug allergic toxicity; neither piecemeal necrosis nor lobular flogosis were found, and immunohistochemical analysis for hepatotropic viruses (HBsAG, HbCAg, CMV, HSV) was negative.
Furthermore, the patient showed diffuse bullous lesions in the oral cavity and perioral region skin with herpetic eruption. Because of the occurrence of anemia and thrombocytopenia, PCR for human herpes viruses was performed and a positive reaction for HHV-1 and HHV-6 was found.
However the patient slowly recovered to a nearly normal hepatic and renal function and steroid therapy was gradually tapered. The patient was transferred into the Gastroenterology Unit. The subsequent clinical course was complicated by diffuse edema, which was treated with loop diuretics and by the occurrence of severe hypertension that required multidrug therapy with ACE inhibitors, calcium antagonists, beta blockers and clonidine. In the following three weeks, the patient completely recovered and, five years later, is now healthy. The complete clinical course is summarized in the (Table 1) .
Discussion
Drug reaction eosinophilia with systemic symptoms (DRESS) syndrome is a rare and potentially life threatening condition related to the usage of various drugs. Its clinical manifestations include erythematous skin rush, fever, mildly enlarged lymphnodes, eosinophilia, and liver and kidney involvement. Most severe forms can lead to acute kidney or liver failure. Typically, the symptoms may persist or worsen despite the withdrawal of the culprit drug. Furthermore, recurrence of the symptoms, although incomplete, may be frequent after the usage of structurally unrelated culprit drugs (1). In the medical literature, 172 cases have been shown to be associated with a large number of drugs (2) . Fever is a frequent accompanying symptom, however, FUO is rarely the first clinical manifestation.
In the present report, we describe a case of DRESS syndrome due to allopurinol treatment, that presented with FUO and rapidly developed life threatening acute kidney and liver (4) reported good diagnostic accuracy for other diagnostic scoring systems, and observed that the lymphocyte and eosinophil count and the creatinine and ferritin serum levels were useful early prognostic factors.
In this system (3), fever is considered only as a minor criterion. As a consequence, the onset of the disease as FUO should be considered as a rare form of syndrome presentation.
Recently, a total of 172 cases of DRESS syndrome were reviewed by Cacoub et al. (1) . Most of those cases were related to the following five drugs: carbamazepine (47 cases). allopurinol (19 cases), lamotrigine (10 cases), phenobarbital (10 cases) and sulfasalazine (10 cases). Moreover, allopurinol therapy was shown to be related to a high risk for cutaneous adverse effects (5) . The link between allopurinol therapy and DRESS syndrome was established in the present case based on the liver and skin biopsy findings and on the epidemiological criteria: furthermore, allopurinol was the causative drug taken by the patient with DRESS syndrome in the review of Cacoub et al (2) , and they reported that allopurinol was the second more frequent causative drug.
According to Hassan et al. (6) , allopurinol toxicity is mediated by the accumulation of its metabolite oxypurinol. Although the pathogenetic mechanism is still unknown, it has been speculated that the accumulation of this metabolite along with immunologic and genetic factors may modify the cellular proteins and trigger an autoimmune response against the skin or liver cells. In some cases (7), severe liver damage may occur mimicking obstructive jaundice and biliary obstruction.
Renal failure and thiazides diuretics treatment may predispose the patient to a severe immunologic reaction. Indeed, our patient was taking hydrochlorothiazide in conjunction with allopurinol. These two drugs are often concurrently prescribed, due the hyperuricemic effect of thiazide diuretics.
Other groups (8, 9) have reported the association of human herpes viruses reactivation, particularly HHV 6, with moresevere disease, in the majority of patients with DRESS syndrome. According to these studies, the causative drug could trigger virus reactivation that generates the selection and proliferation of CD8 + T lymphocytes. The activation of T lymphocytes is responsible for multiple organ damage. In the present case, PCR assay for a HHV-6 and HHV-1 was positive. Conversely, Ishida et al. (10) studied the dynamics of herpes viruses reactivation in a wide group of patients after severe drug reactions, mostly presenting with DRESS syndrome and suggested a relationship between CMV and HHV-6 reactivation with the clinical symptoms related to the viral infection and the immunosuppression due to systemic corticosteroid therapy. In conclusion, the presented case provides the following key points: 1) A fever of unknown origin (FUO) may be an unusual, life-threatening clinical presentation in patients with DRESS syndrome. Therefore, drug-related fever and related syndromes must be kept in mind by the clinician, with prompt suspicion and drug withdrawal, to avoid severe consequences for the patient.
2) The life-threatening course of a poorly understood disease that can potentially occur in a large population of patients taking a commonly used drug was shown.
3) The confirmation of a poorly understood physiopathological correlation with human herpes virus reactivation that could play a role in the pathogenesis of the disease was discussed.
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